These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29048661)

  • 21. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
    Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
    Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
    Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistically Anti-metastatic Effect of 5-Flourouracil on Colorectal Cancer Cells via Calcium-mediated Focal Adhesion Kinase Proteolysis.
    Park M; Sundaramoorthy P; Sim JJ; Jeong KY; Kim HM
    Anticancer Res; 2017 Jan; 37(1):103-114. PubMed ID: 28011480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma.
    Narisawa T; Naito S; Ito H; Ichiyanagi O; Sakurai T; Kato T; Tsuchiya N
    BMC Cancer; 2023 Feb; 23(1):170. PubMed ID: 36803783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
    Kim HJ; Han YS; Lee JH; Lee SH
    Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced efficacy of 5-fluorouracil in combination with a dual histone deacetylase and phosphatidylinositide 3-kinase inhibitor (CUDC-907) in colorectal cancer cells.
    Hamam R; Ali D; Vishnubalaji R; Alsaaran ZF; Chalisserry EP; Alfayez M; Aldahmash A; Alajez NM
    Saudi J Gastroenterol; 2017; 23(1):34-38. PubMed ID: 28139498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
    Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
    Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression.
    Findlay VJ; Wang C; Nogueira LM; Hurst K; Quirk D; Ethier SP; Staveley O'Carroll KF; Watson DK; Camp ER
    Mol Cancer Ther; 2014 Nov; 13(11):2713-26. PubMed ID: 25249558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells.
    Ou QJ; Wu XJ; Peng JH; Zhang RX; Lu ZH; Jiang W; Zhang L; Pan ZZ; Wan DS; Fang YJ
    Mol Med Rep; 2017 Nov; 16(5):5769-5778. PubMed ID: 28849238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro.
    Zhang X; Zhang X; Han R; Wang Z; Yang Q; Huang Y; Yan Y
    Biochem Biophys Res Commun; 2022 Mar; 595():22-27. PubMed ID: 35093636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
    Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies.
    Lang L; Teng Y
    Cells; 2019 Jan; 8(1):. PubMed ID: 30634399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
    Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
    Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer.
    Peláez-García A; Barderas R; Torres S; Hernández-Varas P; Teixidó J; Bonilla F; de Herreros AG; Casal JI
    PLoS One; 2013; 8(5):e63695. PubMed ID: 23696849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
    Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.
    Yu Y; Yu X; Ma J; Tong Y; Yao J
    Int J Oncol; 2016 Jul; 49(1):285-93. PubMed ID: 27176231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.